CEO and co-founder Sentinal4D Eliminating the guesswork in drug discovery via 3D imaging and AI- powered models for personalized therapeutics
Closing 2024 strong! Sentinal4D launch 🚀 is official. I am grateful for our amazing investors, TwinPath Ventures Katie Lockwood ,Arben Ventures and our angel investors James Thomas and Catherine Thomas! The Institute Cancer of Research and Cancer Research Horizons for their continuous support. I am looking forward to focusing on delivering our company’s mission; #personalizedtherapeutics in #oncology with a #biologyfirst #phenotypic-based approach. I am fortunate to work along Chris Bakal and Matt De Vries ! Thank you for the intro Dionysis Panagiotopoulos A huge thank you to all the people who supported me, mentored me and helped me grow professionally. Walter Greenleaf, PhD ,Denise Aronson , Bruce Booth , Andy Molnar , Everett Crosland Amir Lahav AMIR KALALI, MD Andrew Steen Gil Bashe Antony Loebel Amir Rubin Lisa La Luna Vincent Hennemand Taren Grom Melinda Decker SueAnn Sheehan Sharoni Billik, MBA, MBS Stacey Versavel, PhD Ivana Magovcevic-Liebisch, PhD, JD Pamela Gardner Edward Cox Aaron Gani Kimberly Ha Beth Rogozinski Erin Hatzikostas Dennis Olympios and Glen Kazerman
Great news to round out 2024 here at the ICR! 🎄 ✨ 🎇 We're delighted to share that the new ICR spinout company Sentinal4D has been announced to the public. Sentinal4D aims to accelerate drug discovery and development to target drugs to patients, powered via patented artificial intelligence-driven methods for personalised therapeutics. The company is built on years of data and expertise developed in the lab of ICR's Professor Chris Bakal, a leading expert in cell shape in cancer, and includes former ICR PhD Student Matt De Vries. It is led by Dr Georgia Mitsi. Professor Bakal said: “Sentinal4D brings together several strands of expertise we’ve been building in the lab for a number of years – including a deepening understanding of the role of cellular shape-shifting in cancer, innovative new methods of drug discovery, and AI-driven analysis of data including image data" Sentinal4D is the second spinout company to be announced by the ICR this year - as we continue to support our entrepreneurial scientists. Dr Jon Wilkinson, Director of Business and Innovation at the ICR said: “Sentinal4D is the latest of several new spinout companies to emerge from our work at the ICR, as we continue to encourage scientists to found companies as part of the mix of what they do.” Read more here ⬇️ https://lnkd.in/eg5VNrRV
Soooooo great to see this. Congratulations to Georgia Mitsi and the whole team. Wishing this company great success!
Georgia Mitsi - our pleasure! We're really excited to be involved and looking forward to being part of the journey 😃
So happy for you Georgia Mitsi and Chris Bakal !! Maybe the next step is an office in Athens ? Have fun!! 🚀🚀
Amazing! Congrats Georgia Mitsi !! 🚀
Congrats 🎉 Georgia Mitsi
Congratulations Georgia Mitsi! Wishing you all success.
Congratulations. Wishing you the best of success.
Congratulations Georgia!! Excited to see what you will build.
Wonderful news and congratulations, dear Georgia!
Political Science Student at Syracuse University - Maxwell School
1dCongratulations mom! Looking forward to see what you will build! So happy for you! 🎉🎉